StockWatch
·
Other Pharmaceuticals
Quarterly ResultMay 22, 2026, 09:36 AM

Cosmos Health Q1 Revenue Up 31% to $17.9M; Liabilities Down $4.5M

AI Summary

Cosmos Health Inc. reported record first-quarter 2026 results, with revenue increasing 30.7% to $17.93 million. The company also significantly reduced total liabilities by $4.51 million and saw stockholders' equity rise by 7.6%. Despite these improvements, the company reported a net loss of $2.81 million and adjusted EBITDA near breakeven, attributed to strategic investments for global growth, including U.S. expansion.

Key Highlights

  • Cosmos Health Q1 2026 revenue was $17.93 million, up 30.7% from Q1 2025.
  • Adjusted revenue for Q1 2026 was $18.40 million, up 34.2% year-over-year.
  • Gross profit was $1.38 million in Q1 2026, down from $2.05 million in Q1 2025.
  • Net loss was $2.81 million in Q1 2026, compared to a net loss of $0.82 million in Q1 2025.
  • Adjusted EBITDA was ($229,596) in Q1 2026, near breakeven.
  • Total liabilities decreased by $4.51 million (9.6%) to $42.54 million.
  • Total stockholders' equity increased by $1.40 million (7.6%) to $19.83 million.
  • Cash and cash equivalents were $2.16 million as of March 31, 2026.